L
Lunai Bioworks Inc. (LNAI)
NCM – Real Time Price. Currency in USD
0.28
-0.19 (-39.51%)
Market open: Oct 23, 2026, 1:57 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.28
-0.19 (-39.51%)
Market open: Oct 23, 2026, 1:57 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $1.7M significantly exceed its total debt $1.3M, ensuring strong financial flexibility
Total current liabilities $18.9M surpass Total current assets $2.0M, signaling liquidity issues
Debt-to-equity ratio (-0.1) is well below the industry average (0.1), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.8M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.11 | 4.66 | 2.0 | |
| Quick ratio | 0.11 | 4.27 | 2.0 | |
| Debt to Equity | N/A | 0.15 | 1.0 | |
| Debt to Assets | 0.13 | 0.11 | 8.0 | |
| Interest coverage | N/A | -3.18 | 1.0 | |
| Weighted average score | 2.8 | |||
| METRIC | 2023 (Jun 2023) | 2024 (Jun 2024) | 2025 (Jun 2025) | 2026 (Jun 2026) | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 52K | 52K |
| Gross Profit | -113K | -122K | -129K | -42K | -42K |
| Operating Income | -20M | -27M | -19M | -8M | -8M |
| Net Income | -40M | -88M | -178M | -4M | -4M |
| EBITDA | -19M | -27M | -18M | -8M | -8M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | 4.45 | 83.18 | 2.0 | |
| Operating margin % | -6888.56 | -29.82 | 1.0 | |
| Net margin % | -6475.69 | -41.34 | 1.0 | |
| EBITDA margin % | -6793.01 | -26.03 | 1.0 | |
| Cash flow margin % | -5929.20 | -43.91 | 1.0 | |
| Weighted average score | 1.2 | |||
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| ROA | -164.11 | -20.69 | 1.0 | |
| ROE | -330.43 | -17.54 | 1.0 | |
| ROIC | -326.82 | -18.98 | 1.0 | |
| ROCE | N/A | -25.49 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 48.27 | 21.81 | N/A | -79.28 | 5.5 |
| Y/Y | 999 | 98.41 | N/A | -1.64 | 5.5 |
| 3y average | 999 | -42.03 | N/A | 22.66 | 5.5 |
| 5y average | 999 | -77.1 | N/A | 23.36 | 5.5 |
| Weighted average score | 5.5 | ||||
| NAME | RATIO | INDUSTRY | 5Q TREND | SCORE |
|---|---|---|---|---|
| P/E | N/A | 20.20 | 1.0 | |
| PEG (5yr expected) | N/A | 1.20 | 1.0 | |
| P/S | 45.98 | 10.07 | 2.2 | |
| P/B | N/A | 4.38 | 1.0 | |
| Weighted average score | 1.3 | |||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | N/A | 1.20 | N/A |
| Payout ratio | N/A | 27.45 | N/A |
| 5-year dividend growth rate | N/A | 4.94 | N/A |
| Years of dividend increase | 0.00 | 0.00 | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | N/A | N/A |
| Intangible assets | N/A | N/A |
| Switching costs | N/A | N/A |
| Network effect | N/A | N/A |
| Economies of scale | N/A | N/A |
| Weighted average score | 1.0 | |